Compounds > zidovudine
Page last updated: 2024-08-23

zidovudine and Viremia

zidovudine has been researched along with Viremia in 144 studies

Research

Studies (144)

TimeframeStudies, this research(%)All Research%
pre-19903 (2.08)18.7374
1990's96 (66.67)18.2507
2000's37 (25.69)29.6817
2010's8 (5.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilks, CF; Goodall, RL; Gupta, RK; Kaleebu, P; Kityo, C; Lyagoba, F; Mugarura, L; Munderi, P; Pillay, D; Ranopa, M1
Anino, E; Choge, JK; Khayeka-Wandabwa, C; Kweka, EJ; Ngemu, EK; Oyoo-Okoth, E1
Imai, Y; Kawamoto, M; Kohara, N; Sekiya, H; Togo, M; Yoshimura, H1
Benech, H; Bourry, O; Brochard, P; Calvo, J; Dereudre-Bosquet, N; Kazanji, M; Le Grand, R; Makuwa, M; Martinon, F; Souquiere, S1
Bussmann, H; Degruttola, V; Essex, M; Gaolathe, T; Makhema, J; Marlink, RG; Mawoko, N; Mine, M; Moffat, H; Moyo, S; Musonda, R; Muzenda, T; Ndwapi, N; Novitsky, V; Okezie, R; Thomas, A; Wester, CW; Widenfelt, E1
Andreotti, M; Antonelli, G; Ceccarelli, G; d'Ettorre, G; Massetti, P; Mastroianni, CM; Rizza, C; Turriziani, O; Vella, S; Vullo, V1
Cohen, C; DeJesus, E; Elion, R; Gerondelis, P; Ha, B; Horton, J; Lanier, ER; Ross, LL; Rouse, E1
Farquhar, C; John-Stewart, GC; Katz, DA; Lohman-Payne, B; Mabuka, JM; Majiwa, M; Richardson, BA1
Benech, H; Bourry, O; Dereuddre-Bosquet, N; Durand-Gasselin, L; Le Grand, R; Mannioui, A; Roques, P; Roucairol, C; Sellier, P1
Fogle, JE; Miller, MM1
Brunet, C; Bui, E; De Saint Martin, L; Jovelin, T; Le Moal, G; Perfezou, P; Raffi, F; Reliquet, V; Venisse, N; Winer, N1
Chantawuttinan, T; Dabtham, K; Hawkins, D; Hill, AM; Kanshana, S; Moyle, GJ; Sirichthaporn, P; Somburanasin, P; Supajatura, V; Vithayasai, V; Wattanatchariya, N1
Domínguez Castellanos, A; Justo Alpañés, E; Orbea Ríos, L1
Bergallo, M; Bollero, C; Cavallo, R; Lembo, D; Leonardi, G; Merlino, C; Musso, T; Ponzi, AN; Re, D; Segoloni, GP1
Collier, AC; Coombs, RW; Lockhart, D; Marra, CM; Perrin, M; Zunt, JR1
Brault, C; Chennebault, JM; Loison, J; Payan, C; Peigne, M1
Albert, J; Blaxhult, A; Brandin, E; Broström, C; Gisslen, M; Gyllensten, K; Hagberg, L; Lindborg, L; Tuvesson, B1
Bower, M; Davies, E; Gazzard, B; Latham, V; Mandalia, S; Michailidis, C; Nelson, M; Stebbing, J1
Amel, EB; Amel, LO; Amine, SM; Asma, J; Fethi, T; Mohamed, C; Mounira, G; Taoufik, BC1
Antunes, F; Chiesi, A; Goebel, FD; Katlama, C; Knysz, B; Ledergerber, B; Lundgren, JD; Mocroft, A; Phillips, AN; Reiss, P1
López, G; Omiste, T; Ramos, C; Ruiz, M1
Giry, C; Hebert, JC; Lartigau-Roussin, C; Malvy, D; Pettinelli, ME; Receveur, MC1
Ansari, AW; Heiken, H; Schmidt, RE1
Anderson, AM; Bartlett, JA; Kosinski, AS1
Fessel, WJ1
Schwartz, DH1
Chiodi, F; Di Stefano, M; Hagberg, L; Leitner, T; Norkrans, G; Sabri, F; Svennerholm, B1
Chen, S; Chopra, P; Emini, EA; Hahn, BH; Kappes, JC; McFarland, R; Piatak, M; Saag, MS; Shaw, GM; Yang, LC1
de la Iglesia, P; de Oña Navarro, M; Fernández Urgellés, M; Martinez Gutierrez, A; Melón Garcia, S; Mendez García, FJ; Rodriguez Pinto, C1
Bartlett, JA; Cohen, OJ; Graziosi, C; Holodniy, M; Lalezari, J; Niu, M; Pantaleo, G; Pavlakis, GN; Schnittman, S; Steigbigel, RT1
Ho, DD1
Bagnarelli, P; Clementi, M; Manzin, A; Menzo, S; Paolucci, S; Petroni, S; Sampaolesi, R; Scalise, G; Valenza, A; Varaldo, PE1
Amato, DA; DeGruttola, V; Eyster, ME; Gjerset, GF; Ho, M; Kessler, CM; LoFaro, ML; Parenti, DM; Ragni, MV; Van Der Horst, C1
Balfe, P; Bonhoeffer, S; Kaye, S; Loveday, C; Nowak, MA; Semple, M; Tedder, R; Tenant-Flowers, M1
Francke, S; Frick, R; Hayes, KA; Mathes, LE; Wilkinson, JG1
Anderson, BD; Broder, S; Chokekijchai, S; Kojima, E; Mitsuya, H; Shirasaka, T; Steinberg, SM; Yarchoan, R1
Bariou, C; Cartier, F; Colimon, R; Genetet, N; Guist'hau, O; Jacquelinet, C; Michelet, C; Ruffault, A1
Carroll, R; Holodniy, M; Margolis, D; Mole, L; Todd, J1
Boota, A; Cheeseman, SH; Fischl, MA; Meng, TC; Petrakis, T; Resnick, L; Richman, DD; Spector, SA; Wright, B1
Baumberger, C; Hirschel, B; Kaiser, L; Perrin, LH; Yerly, S1
Clark, SJ; Hahn, BH; Kappes, JC; Lifson, JD; Luk, KC; Piatak, M; Saag, MS; Shaw, GM; Yang, LC1
Barateau, V; Chevret, S; Ferchal, F; Modai, J; Molina, JM; Morinet, F; Poirot, C1
de Micco, P; Lafeuillade, A; Pellegrino, P; Quilichini, R; Tamalet, C; Vignoli, C1
Bush, CE; Cohen, F; Donovan, RM; Moore, E; Saravolatz, LD; Smereck, SM1
Blanes, N; Coutellier, A; Fenouillet, E; Gluckman, JC1
Marthas, ML; Pedersen, NC; van Rompay, KK1
Erickson, JG; Hayes, KA; Lafrado, LJ; Marr, JM; Mathes, LE1
Hoover, EA; Mathiason-DuBard, CK; Zeidner, NS1
Bartz, CR; Benveniste, RE; Follis, KE; Grant, RF; Nolte, RE; Sager, PR; Tsai, CC1
Clarke, JR; Mitchell, DM; Williamson, JD1
Bartocci, C; Buffarini, F; Butini, L; Danieli, G; Montroni, M; Regnery, C; Silvestri, G1
Davey, RT; Dewar, RL; Falloon, J; Haneiwich, SE; Kovacs, JA; Masur, H; Polis, MA; Reed, GF; Vasudevachari, MB; Walker, RE1
Barker, E; Elbeik, T; Guthrie, J; Levy, JA; Ramachandran, B1
Bernard, N; Bonot, P; Fleury, HJ; Legrand, E; Masquelier, B; Neau, D; Pellegrin, I; Pellegrin, JL; Ragnaud, JM1
Benveniste, O; Clayette, P; Dormont, D; Frétier, P; Le Grand, R; Le Naour, R; Noack, O; Théodoro, F; Vaslin, B1
Kovacs, A; Li, Z; Rasheed, S; Xu, D1
Costes, O; Lafeuillade, A; Poggi, C; Profizi, N; Tamalet, C1
Cosín, J; Fernández-Cruz, E; Montes, MG; Muñoz-Fernández, MA; Navarro, J; Zabay, JM1
Anderson, B; Farley, M; Fox, C; Luzuriaga, K; Mueller, BU; Pizzo, PA; Schwartzentruber, DJ; Sei, S; Sullivan, JL; Tudor-Williams, G; Venzon, DJ1
Baxa, D; Bush, CE; Cohen, F; Donovan, RM; Manzor, O; Moore, E; Saravolatz, LD1
Slavkin, HC1
Hayes, KA; Kociba, G; Mathes, LE1
Baumberger, C; Hirschel, B; Kinloch-de Loës, S; Pechère, M; Perrin, L; Rakik, A; Yerly, S1
Caruz, A; Leal, M; Lissen, E; Medrano, FJ; Rey, C; Sánchez-Quijano, A; Torres, Y1
Boucher, CA; Brun-Vezinet, F; Descamps, D; Kaye, S; Loveday, C; Schuurman, R; Tedder, R; Tijnagel, J; van Leeuwen, R; Weverling, GJ; Williams, I1
Belohradsky, BH; Eberle, J; Gürtler, L; Notheis, G; Sölder, B; Wintergerst, U1
Bouza, E; Miró, JM; Pumarola, T; Soriano, V1
Bürgisser, P; Meylan, PR; Pagani, JL; Spertini, F; Weyrich-Suter, C1
Cao, Y; Essunger, P; Ho, DD; Hurley, A; Markowitz, M; Perelson, AS; Saksela, K; Vesanen, M1
Brizzi, M; Ceccherini-Nelli, L; Forastieri, G; Iuliano, R; Mazzotta, F; Mecocci, L1
Fantini, J; Lafeuillade, A; Poggi, C; Tamalet, C; Yahi, N1
Autran, B; Blanc, C; Carcelain, G; Debré, P; Katlama, C; Leibowitch, J; Li, TS; Mathez, D; Tubiana, R1
Comar, M; De Paoli, P; Giacca, M; Simonelli, C; Tirelli, U; Zanussi, S1
Boucher, CA; de Boer, RJ; de Jong, MD; de Wolf, F; Foudraine, NA; Goudsmit, J; Lange, JM1
Aiuti, F; Alario, C; Bernardi, ML; Carlesimo, M; Cassone, A; Guerra, EC; Leone, P; Mattiacci, G; Pirillo, MF; Pontesilli, O; Ricci, G; Varani, AR1
Günthard, HF; Havlir, DV; Hezareh, M; Ignacio, CC; Richman, DD; Spina, CA; Wong, JK1
Comar, M; De Paoli, P; Giacca, M; Simonelli, C; Tirelli, U; Vaccher, E; Zanussi, S1
Goldstein, H; Katopodis, NF; Kim, A; Kollmann, TR; Pettoello-Mantovani, M; Raker, C; Wiltshire, H; Yurasov, S1
Bagnarelli, P; Butini, L; Montroni, M; Munoz, C; Silvestri, G1
Spooner, KM1
Leal, M; Lissen, E; Pineda, JA; Rey, C; Rubio, A; Sanchez-Quijano, A1
Collier, AC; Coombs, RW; Corey, L; Panther, LA; Zeh, JE1
Dal Pan, GJ; Farzadegan, H; Hoover, DR; McArthur, JC; Miller, EN; Nance-Sproson, TE; Selnes, O; Skolasky, RL1
Aiuti, F; Ammassari, A; Antinori, A; Carlesimo, M; Guerra, EC; Ortona, L; Pontesilli, O; Prozzo, A; Seeber, AC; Tamburrini, E; Tomino, C; Vella, S1
Blanchard, G; Blum, L; Calvo, F; Danne, O; Lebbé, C; Morel, P; Pellet, C; Vérola, O1
Contopoulos-Ioannidis, DG; Ioannidis, JP1
Baumgartner, EM; Feucht, HH; Laufs, R; Schröter, M; Stellbrink, HJ; Zöllner, B1
Al-Shboul, Q; Day, RD; Fan, Z; Huang, XL; Liebmann, JM; McMahon, DK; Mellors, JW; Riddler, SA; Rinaldo, CR1
Binley, JM; Cao, Y; Chaudhry, MR; Frankel, S; Heath-Chiozzi, M; Ho, DD; Hurley, A; J, X; Jin, X; Leonard, JM; Markowitz, M; Moore, JP; Nixon, DF; Racz, P; Talal, A; Tenner-Racz, K; Vesanen, M; Yaman, M1
Carr, A; Cooper, DA; Cunningham, PH; Grey, P; Jaramillo, AB; Kaufmann, GR; Kelleher, AD; Smith, D; Vizzard, J; Wright, R; Zaunders, JJ1
Chêne, G; Cotte, L; Debord, T; Decazes, JM; Ferchal, F; Journot, V; Madelaine, I; Molina, JM; Pellegrin, I; Rancinan, C; Sombardier, MN1
Goulder, PJ; Jones, NG; Kalams, SA; Ogg, GS; Shea, AK; Trocha, AK; Walker, BD1
Hogg, RS; Jahnke, N; Montaner, JS; O'Shaughnessy, M; Yip, B1
Belfrage, E; Bohlin, AB; Christensson, B; Ehrnst, A; Lidin-Janson, G; Ljung, R; Navér, L; Sönnerborg, A1
Alesse, E; Boschini, A; Cifone, MG; De Simone, C; Di Marzio, L; Famularo, G; Marcellini, S; Moretti, S; Parroni, R; Zazzeroni, F1
Asjö, B; Dyrhol-Riise, AM; Olofsson, J; Voltersvik, P1
Arrizabalaga, J; Clotet, BG; Cruceta, A; Dalmau, D; Gallart, T; García, F; Gatell, JM; Gomez-Sirvent, JL; Grau, I; Knobel, H; Miró, JM; O'Brien, WA; Podzamczer, D; Pumarola, T; Romeu, J; Sambeat, MA1
Antunes, F; Brown, DJ; Clumeck, N; Fetter, A; Haubrich, R; Kahl, L; Lang, W; Pagano, G; Richman, D; Schooley, R; Sereni, D; Stein, A; Thompson, M; van der Ende, ME1
Asjö, B; Baklien, K; Brantsaeter, AB; Bruun, JN; Dunlop, O; Dyrhol-Riise, AM; Røsok, BI; Skar, AG1
Albrecht, H; Hufert, FT; Lauer, J; Racz, P; Schneider, C; Stellbrink, HJ; Tenner-Racz, K; van Lunzen, J1
Campi, G; Casorati, G; Corey, L; Demarest, JF; Kaufmann, D; Lazzarin, A; Lenge, C; Pantaleo, G; Rizzardi, GP; Soudeyns, H; Tambussi, G1
Asjö, B; Dyrhol-Riise, AM; Olofsson, J; Røsok, BI; Voltersvik, P1
Bart, PA; Chapuis, A; De Boer, RJ; Fox, CH; Halkic, N; Hoover, S; Lange, JM; Lazzarin, A; Miller, V; Notermans, DW; Pantaleo, G; Perrin, L; Rizzardi, GP; Staszewski, S; Tambussi, G1
Bray, D; Clerici, M; Colombo, F; Dix, LP; Fusi, ML; Milazzo, F; Piconi, S; Rizzardini, G; Trabattoni, D1
Chodakewitz, JA; Condra, JH; Emini, EA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Isaacs, R; Jonas, L; McMahon, D; Meibohm, A; Mellors, JW; Richman, DD; Valentine, FT1
Chieco-Bianchi, L; De Rossi, A; Del Mistro, A; Giaquinto, C; Zamarchi, R1
Busch, M; Hecht, FM; Kahn, J; Levy, JA; Martinez-Marino, B; Ong, JC; Stranford, SA1
Alejo, A; García, ML; Palomares, JC; Perea, EJ; Romero, J; Terrero, E; Torres, MJ1
Achilli, G; Bruno, R; Debiaggi, M; Filice, G; Patruno, SF; Pistorio, A; Romero, E; Sacchi, P; Zara, F1
Dabis, F; Leroy, V; Manigart, O; Meda, N; Montcho, C; Msellati, P; Rouzioux, C; Simonon, A; Van de Perre, P; You, B1
Brown, AJ; Emini, E; Eron, J; Fiscus, S; Frost, SD; Gamagami, R; Gulick, R; Günthard, HF; Haase, A; Havlir, DV; Ignacio, CC; Isaacs, R; Jonas, L; Meibohm, A; Mellors, J; Richman, DD; Schleif, W; Valentine, F; Wong, JK; Zhang, ZQ1
Achilli, G; Bruno, R; De Santolo, A; Debiaggi, M; Filice, G; Maserati, R; Pistorio, A; Romero, E; Sacchi, P; Spinillo, A; Zara, F1
Altisent, C; Bravo, R; García-Samaniego, J; Gómez-Cano, M; González-Lahoz, J; Ruiz, I; Soriano, V1
Caruz, A; Leal, M; Lissen, E; Pineda, JA; Relimpio, F; Rey, C; Sánchez-Quijano, A1
Jackson, JB1
Japour, AJ1
Chang, HE1
Asjö, B; Berg, OG; Dyrhol-Riise, AM; Kleivbo, S; Olofsson, J; Voltersvik, P1
Bassett, R; Collier, AC; Condra, J; Gilbert, P; Günthard, HF; Havlir, DV; Hirsch, MS; Ignacio, C; Levitan, D; Richman, DD; Tebas, P; Wong, JK1
Becker, S; Fisher, R; Graham, N; Henry, K; Hernandez, J; Hirani, A; Liao, Q; Raffanti, S; Ross, L; Scarsella, A; St Clair, M1
Andersson, J; Cooper, D; Goh, LE; Hoen, B; Janossy, G; Kinloch, S; Lampe, F; Perrin, L; Tilling, R; Tsoukas, C; Zaunders, J1
Cai, W; Cao, Y; Ding, Y; Gao, M; Li, L; Mei, S; Zhang, F1
Gazzard, BG; Moyle, GJ1
Perrin, L1
Ray, SC; Sulkowski, MS; Thomas, DL1
Agut, H; Brun-Vézinet, F; Ferchal, F; Fleury, H; Masquelier, B; Puel, J; Rouzioux, C; Tamalet, C1
Boulberhane, A; Hellman, KB; Pierce, PF; Shepherd, LP; Ved Brat, SS1
Angarano, G; Di Stefano, M; Fico, C; Fiore, JR; Fracasso, C; Grottola, A; Monno, L; Pastore, G1
Akerlund, B; Andersson, J; Berglund, O; Ehrnst, A; Engman, K; Lidman, K; Sönnerborg, A; Strannegård, O1
Brown, WE; Campbell-Hill, S; Crain, MJ; Decker, WD; Hahn, BH; Leuther, M; Robinson, S; Saag, MS; Shaw, GM; Whitley, RJ1
Emery, VC; Griffiths, PD; McLean, AR; Webster, A1
Bubp, JL; Holodniy, M; Israelski, DM; Katzenstein, DA; Merigan, TC; Mole, LA; Sengupta, S1
Balzarini, J; Bronson, R; De Clercq, E; Jaenisch, R; Lee, JS; Mullaney, S; Ruprecht, RM; Sharpe, AH1
Loveday, C; Semple, M; Tedder, R; Weller, I1
Morrey, JD; Okleberry, KM; Sidwell, RW1
Angarano, G; Barile, M; Fico, C; Fiore, JR; Fracasso, C; Lo Caputo, S; Pastore, G1
Chipty, F; Chou, TC; Mullaney, S; O'Brien, L; Rosas, D; Ruprecht, RM; Sosa, MG1
Atoui, N; Blanc, P; Ducos, J; Mandin, J; Reynes, J; Segondy, M; Vendrell, JP1
Ruprecht, RM1
Alam, M; Ho, DD; Moudgil, T1
Bjornson, DC; Burke, DS; Fowler, AK; Oster, CN; Redfield, RR1

Reviews

4 review(s) available for zidovudine and Viremia

ArticleYear
B19 virus infection in renal transplant recipients.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003, Volume: 26, Issue:3

    Topics: Anemia; Antibodies, Monoclonal; Antibodies, Viral; Antilymphocyte Serum; Basiliximab; Cyclosporine; Cytomegalovirus Infections; Diagnosis, Differential; Disease Susceptibility; DNA, Viral; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukin-1; Kidney Transplantation; Male; Mycophenolic Acid; Parvoviridae Infections; Parvovirus B19, Human; Phosphoproteins; Polymerase Chain Reaction; Postoperative Complications; Prednisone; Recombinant Fusion Proteins; Retrospective Studies; T-Lymphocytes; Tacrolimus; Viral Load; Viral Matrix Proteins; Viremia; Zidovudine

2003
[Monitoring anti-retroviral treatment].
    Enfermedades infecciosas y microbiologia clinica, 1996, Volume: 14 Suppl 1

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Evaluation; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Phenotype; RNA, Viral; Viremia; Zidovudine

1996
Antiretroviral therapy in human immunodeficiency virus-infected individuals.
    Advances in internal medicine, 1998, Volume: 43

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chemoprevention; Clinical Protocols; Decision Making; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Patient Care Planning; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine

1998
Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Jun-01, Volume: 18, Issue:2

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; ROC Curve; Viral Load; Viremia; Zidovudine

1998

Trials

34 trial(s) available for zidovudine and Viremia

ArticleYear
High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:7

    Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Humans; Lamivudine; Nevirapine; Viral Load; Viremia; Zidovudine

2014
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
    BMC research notes, 2014, Jan-21, Volume: 7

    Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Counseling; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Infusions, Intravenous; Kenya; Lamivudine; Medication Adherence; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Socioeconomic Factors; Viral Load; Viremia; Young Adult; Zidovudine

2014
Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
    Journal of acquired immune deficiency syndromes (1999), 2009, May-01, Volume: 51, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Botswana; CD4 Lymphocyte Count; Didanosine; Drug Tolerance; Female; HIV Infections; HIV-1; Humans; Male; Patient Compliance; RNA, Viral; Survival Analysis; Time Factors; Viremia; Zidovudine

2009
Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohort.
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:9

    Topics: Adult; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cohort Studies; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Ritonavir; Saquinavir; Treatment Outcome; Viral Load; Viremia; Young Adult; Zidovudine

2012
Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission.
    Journal of acquired immune deficiency syndromes (1999), 2002, Aug-01, Volume: 30, Issue:4

    Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Safety; Saquinavir; Thailand; United Kingdom; Viremia; Zidovudine

2002
Effects on immunological and virological outcome of patients using one protease inhibitor or one non-nucleoside reverse transcriptase inhibitor in a triple antiretroviral therapy: normal clinical practice versus clinical trial findings.
    Current HIV research, 2005, Volume: 3, Issue:3

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Retrospective Studies; Treatment Outcome; Tunisia; Viremia; Zidovudine

2005
Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Oct-01, Volume: 10, Issue:2

    Topics: Antiviral Agents; Benzoxazoles; Biomarkers; CD4 Lymphocyte Count; Double-Blind Method; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Immunoassay; Polymerase Chain Reaction; Prospective Studies; Pyridones; Reverse Transcriptase Inhibitors; RNA, Viral; Viremia; Zidovudine

1995
Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Jun-20, Volume: 92, Issue:13

    Topics: Adult; Didanosine; DNA, Viral; Female; HIV Infections; HIV-1; Humans; Lymph Nodes; Lymphocytes; Male; Time Factors; Viremia; Zidovudine

1995
Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups.
    Blood, 1995, May-01, Volume: 85, Issue:9

    Topics: Adult; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Didanosine; Drug Therapy, Combination; Female; Hemophilia A; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Safety; Treatment Outcome; Viremia; Zidovudine

1995
Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy.
    The Journal of infectious diseases, 1995, Volume: 171, Issue:5

    Topics: Adult; Base Sequence; CD4 Lymphocyte Count; Codon; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genes, pol; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; RNA, Viral; Viremia; Zidovudine

1995
Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Feb-01, Volume: 8, Issue:2

    Topics: Adult; CD4 Immunoadhesins; CD4 Lymphocyte Count; Drug Interactions; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; Humans; Male; Middle Aged; Safety; United States; Viremia; Zidovudine

1995
Antiretroviral therapy is associated with a decrease in unintegrated HIV-1 DNA in pediatric patients.
    Journal of acquired immune deficiency syndromes, 1994, Volume: 7, Issue:12

    Topics: CD4 Lymphocyte Count; Child, Preschool; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Leukocytes, Mononuclear; Male; Polymerase Chain Reaction; Viremia; Zidovudine

1994
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Jun-15, Volume: 90, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Benzoxazoles; beta 2-Microglobulin; Biomarkers; CD4 Antigens; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Male; Neoplasms; Pyridones; Time Factors; Viremia; Zidovudine

1993
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Journal of clinical microbiology, 1996, Volume: 34, Issue:12

    Topics: Biomarkers; Cross-Sectional Studies; HIV Infections; HIV-1; Humans; Laboratories; Longitudinal Studies; Reproducibility of Results; RNA, Viral; Viremia; Virology; Virus Replication; Zidovudine

1996
Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration.
    The Journal of infectious diseases, 1997, Volume: 175, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biopsy, Needle; CD4 Lymphocyte Count; CD4-CD8 Ratio; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; HIV-1; Humans; Lymph Nodes; Polymerase Chain Reaction; Regression Analysis; RNA Splicing; RNA, Viral; Saquinavir; Single-Blind Method; Viremia; Zalcitabine; Zidovudine

1997
Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Science (New York, N.Y.), 1997, Jul-04, Volume: 277, Issue:5322

    Topics: Adult; Anti-HIV Agents; Antigens, Viral; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Homeostasis; Humans; Immunologic Memory; Lymphocyte Activation; Lymphocyte Count; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; T-Lymphocyte Subsets; Tuberculin; Viral Load; Viremia; Zalcitabine; Zidovudine

1997
No therapeutic advantage from didanosine (ddI) and hydroxyurea versus ddI alone in patients with HIV infection.
    AIDS (London, England), 1997, Volume: 11, Issue:10

    Topics: CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; RNA, Viral; Treatment Outcome; Viremia; Zidovudine

1997
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected persons.
    The Journal of infectious diseases, 1997, Volume: 176, Issue:4

    Topics: Adolescent; Adult; Anti-HIV Agents; Antibodies, Monoclonal; CD3 Complex; Cytotoxicity Tests, Immunologic; Double-Blind Method; Female; Flow Cytometry; HIV Antigens; HIV Envelope Protein gp160; HIV Infections; HIV-1; Humans; Immunity, Active; Immunity, Cellular; Immunologic Memory; Male; Middle Aged; Recombinant Proteins; RNA, Viral; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Vaccination; Vaccines, Synthetic; Viral Proteins; Viremia; Zidovudine

1997
Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemia.
    AIDS (London, England), 1998, Jan-01, Volume: 12, Issue:1

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Interleukin-2; Leukocyte Common Antigens; Male; Pilot Projects; RNA, Viral; Viremia; Zidovudine

1998
HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS (London, England), 1998, Mar-05, Volume: 12, Issue:4

    Topics: Aging; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Double-Blind Method; Drug Resistance, Microbial; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Point Mutation; Quality Control; RNA, Viral; Viral Load; Viremia; Zidovudine

1998
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team.
    AIDS (London, England), 1998, Mar-26, Volume: 12, Issue:5

    Topics: Adolescent; Adult; AIDS Vaccines; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Double-Blind Method; Female; HIV Envelope Protein gp160; HIV Infections; HIV-1; Humans; Lymphocytes; Male; Middle Aged; RNA, Viral; Time Factors; Vaccines, Synthetic; Viremia; Zidovudine

1998
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.
    The Journal of infectious diseases, 1999, Volume: 179, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antigens, Bacterial; CD4-Positive T-Lymphocytes; Cell Division; Chemokines; Cytokines; Double-Blind Method; Female; HIV Antigens; HIV-1; Humans; Indinavir; Lamivudine; Male; Mitogens; RNA, Viral; Viremia; Zidovudine

1999
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.
    The Journal of infectious diseases, 1999, Volume: 179, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Therapy, Combination; HIV-1; Homosexuality, Male; Humans; Lamivudine; Male; Middle Aged; Pilot Projects; Ritonavir; RNA, Viral; T-Lymphocytes, Cytotoxic; Time Factors; Viremia; Virus Replication; Zidovudine

1999
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    The Journal of infectious diseases, 1999, Volume: 180, Issue:2

    Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; DNA, Viral; Drug Therapy, Combination; HIV Antibodies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Prospective Studies; RNA, Viral; T-Lymphocyte Subsets; Viremia; Zidovudine

1999
The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.
    The Journal of infectious diseases, 1999, Volume: 180, Issue:2

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viremia; Zidovudine

1999
Long-term pattern of HIV-1 RNA load in perinatally infected children.
    Scandinavian journal of infectious diseases, 1999, Volume: 31, Issue:4

    Topics: CD4 Lymphocyte Count; Child, Preschool; Disease Progression; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Linear Models; Male; Monitoring, Physiologic; Pregnancy; Prospective Studies; Risk Factors; RNA, Viral; Sensitivity and Specificity; Statistics, Nonparametric; Sweden; Viral Load; Viremia; Zidovudine

1999
Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis.
    Immunopharmacology and immunotoxicology, 1999, Volume: 21, Issue:4

    Topics: Adult; Anti-HIV Agents; Apoptosis; Caspase 1; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Ceramides; Didanosine; Drug Therapy, Combination; fas Receptor; HIV Infections; HIV-1; Humans; Male; Mitochondria; Viral Load; Viremia; Zidovudine

1999
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Palatine Tonsil; Ritonavir; RNA, Viral; Spain; Stavudine; Viremia; Zalcitabine; Zidovudine

1999
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team.
    AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17

    Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Female; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nausea; RNA, Viral; Safety; Sulfonamides; Time Factors; Viremia; Zidovudine

1999
Effect of two different combinations of antiretrovirals (AZT+ddI and AZT+3TC) on cytokine production and apoptosis in asymptomatic HIV infection.
    Antiviral research, 2000, Volume: 46, Issue:3

    Topics: Anti-HIV Agents; Apoptosis; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cytokines; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Prospective Studies; Reverse Transcriptase Inhibitors; Th1 Cells; Viremia; Zidovudine

2000
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
    Annals of internal medicine, 2000, Jul-04, Volume: 133, Issue:1

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Genotype; HIV; HIV Infections; Humans; Indinavir; Kidney Calculi; Lamivudine; Male; Middle Aged; RNA, Viral; Viral Load; Viremia; Zidovudine

2000
Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.
    AIDS (London, England), 2001, Mar-09, Volume: 15, Issue:4

    Topics: Africa; Breast Feeding; Case-Control Studies; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Viral Load; Viremia; Zidovudine

2001
[A clinical trial using zidovudine and lamivudine plus indinavir triple therapy in Chinese individuals with human immunodeficiency virus infection].
    Zhonghua nei ke za zhi, 2002, Volume: 41, Issue:2

    Topics: Adult; Aged; Anti-HIV Agents; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; China; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; RNA, Viral; Time Factors; Treatment Outcome; Viremia; Zidovudine

2002
Therapeutic vaccination in primary HIV infection, the Quest trial.
    Vaccine, 2002, May-06, Volume: 20, Issue:15

    Topics: AIDS Vaccines; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carbamates; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Defective Viruses; Dideoxynucleosides; Furans; HIV Infections; Humans; Immunotherapy, Active; Lamivudine; Lymphocyte Count; Sulfonamides; T-Lymphocyte Subsets; Vaccination; Vaccinia virus; Viral Load; Viral Vaccines; Viremia; Zidovudine

2002

Other Studies

106 other study(ies) available for zidovudine and Viremia

ArticleYear
[HIV encephalopathy due to drug resistance despite 2-year suppression of HIV viremia by cART].
    Rinsho shinkeigaku = Clinical neurology, 2014, Volume: 54, Issue:9

    Topics: AIDS Dementia Complex; Anti-Retroviral Agents; Central Nervous System; Cognition Disorders; Darunavir; Disease Progression; Drug Resistance, Viral; Drug Substitution; HIV; HIV Infections; Humans; Male; Middle Aged; Pyrrolidinones; Raltegravir Potassium; Ritonavir; RNA, Viral; Sulfonamides; Time Factors; Viremia; Zidovudine

2014
Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.
    AIDS (London, England), 2009, Feb-20, Volume: 23, Issue:4

    Topics: Administration, Oral; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Indinavir; Injections, Subcutaneous; Lamivudine; Macaca fascicularis; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Vagina; Viral Load; Viremia; Zidovudine

2009
The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:4

    Topics: Adenine; Anti-HIV Agents; Cohort Studies; Drug Combinations; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Mutation; Organophosphonates; Prospective Studies; Tenofovir; Viremia; Zidovudine

2009
Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:2

    Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Organophosphonates; RNA, Viral; Tenofovir; Treatment Failure; Viremia; Young Adult; Zidovudine

2010
CCR5, RANTES and SDF-1 polymorphisms and mother-to-child HIV-1 transmission.
    International journal of immunogenetics, 2010, Volume: 37, Issue:4

    Topics: Adolescent; Adult; Anti-HIV Agents; Body Fluids; Cervix Uteri; Chemokine CCL5; Chemokine CXCL12; Cohort Studies; Female; Genetic Predisposition to Disease; Gestational Age; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Milk, Human; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Infectious; Receptors, CCR5; Viral Load; Viremia; Young Adult; Zidovudine

2010
Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion.
    Retrovirology, 2010, Sep-26, Volume: 7

    Topics: Administration, Cutaneous; Administration, Oral; Animals; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; HIV Protease Inhibitors; Indinavir; Lamivudine; Macaca fascicularis; Male; Reverse Transcriptase Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Tissue Distribution; Viremia; Zidovudine

2010
Administration of Fozivudine tidoxil as a single-agent therapeutic during acute feline immunodeficiency virus infection does not alter chronic infection.
    Viruses, 2012, Volume: 4, Issue:6

    Topics: Animals; Anti-HIV Agents; Cat Diseases; Cats; CD4-CD8 Ratio; Feline Acquired Immunodeficiency Syndrome; Lipids; Lymphocyte Count; Treatment Outcome; Viral Load; Viremia; Zidovudine

2012
[Mononucleosis syndrome with viro-immunologic parameters similar to those of a primary HIV-1 infection after interruption of highly effective anti-retroviral treatment].
    Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:6

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; Depression; Didanosine; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Mononucleosis; Male; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Treatment Refusal; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Viremia; Zalcitabine; Zidovudine

2002
Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy.
    Neurology, 2003, Apr-22, Volume: 60, Issue:8

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cognition Disorders; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Middle Aged; Neuropsychological Tests; RNA, Viral; Time Factors; Viral Load; Viremia; Zidovudine

2003
[Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2003, Volume: 10, Issue:2

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Viral Load; Viremia; Zidovudine

2003
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
    AIDS research and human retroviruses, 2003, Volume: 19, Issue:7

    Topics: Adolescent; Adult; Africa, Western; Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; Codon; Drug Resistance, Multiple, Viral; Evolution, Molecular; Female; Genes, pol; Genetic Variation; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Nelfinavir; Prospective Studies; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Sequence Alignment; Sequence Homology, Amino Acid; Sweden; Treatment Failure; Viremia; Zidovudine

2003
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Erythrocyte Indices; Humans; Lamivudine; Organophosphonates; Patient Compliance; Salvage Therapy; Tenofovir; Viral Load; Viremia; Zidovudine

2005
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
    AIDS (London, England), 2006, May-12, Volume: 20, Issue:8

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load; Viremia; Zidovudine

2006
[Sustained spontaneous remission of chronic hepatitis C coinfection in HIV].
    Enfermedades infecciosas y microbiologia clinica, 2007, Volume: 25, Issue:4

    Topics: Adult; Anti-HIV Agents; Didanosine; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Remission, Spontaneous; Viremia; Zidovudine

2007
[Update on HIV infection in Mayotte].
    Medecine tropicale : revue du Corps de sante colonial, 2007, Volume: 67, Issue:2

    Topics: Adult; Anti-HIV Agents; Comoros; Dideoxynucleosides; Drug Combinations; Female; Heterosexuality; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Lamivudine; Male; Middle Aged; Transfusion Reaction; Viremia; Zidovudine

2007
Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings.
    Clinical immunology (Orlando, Fla.), 2007, Volume: 125, Issue:1

    Topics: Alkynes; Anti-HIV Agents; Anti-Inflammatory Agents; Benzoxazines; Chemokine CCL2; Cyclopropanes; Drug Resistance, Viral; Flow Cytometry; Gene Expression; HIV Infections; HIV-1; Humans; In Vitro Techniques; Interleukin-8; Lamivudine; Male; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Uveitis; Viral Load; Viremia; Zidovudine

2007
Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
    Antiviral therapy, 2007, Volume: 12, Issue:7

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Female; HIV; HIV Infections; Humans; Male; RNA, Viral; Stavudine; Viral Load; Viremia; Zidovudine

2007
Early treatment of HIV infection.
    The New England journal of medicine, 1995, Dec-28, Volume: 333, Issue:26

    Topics: Antiviral Agents; Costs and Cost Analysis; HIV Infections; HIV-1; Humans; RNA, Viral; Viremia; Zidovudine

1995
Early treatment of HIV infection.
    The New England journal of medicine, 1995, Dec-28, Volume: 333, Issue:26

    Topics: Antiviral Agents; HIV Infections; HIV-1; Humans; Viremia; Zidovudine

1995
Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.
    Journal of clinical microbiology, 1995, Volume: 33, Issue:2

    Topics: AIDS Dementia Complex; Base Sequence; Brain; Codon; DNA Primers; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Time Factors; Viremia; Zidovudine

1995
Prospective study of antigenemia, plasma viremia and lymphocytic viremia in HIV-infected hemophiliacs.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1995, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Biomarkers; Hemophilia A; HIV Antigens; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Lymphocytes; Prognosis; Prospective Studies; Viremia; Zidovudine

1995
Time to hit HIV, early and hard.
    The New England journal of medicine, 1995, Aug-17, Volume: 333, Issue:7

    Topics: HIV Infections; HIV-1; Humans; Time Factors; Viremia; Zidovudine

1995
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.
    Journal of clinical microbiology, 1995, Volume: 33, Issue:1

    Topics: Amino Acid Sequence; Didanosine; DNA, Viral; Female; Genes, pol; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Male; Molecular Sequence Data; Mutagenesis; RNA, Viral; Sequence Analysis, DNA; Transcription, Genetic; Viremia; Zidovudine

1995
HIV results in the frame. Results confirmed.
    Nature, 1995, May-18, Volume: 375, Issue:6528

    Topics: Cohort Studies; HIV Infections; Humans; Male; Viremia; Zidovudine

1995
Early suppression of viremia by ZDV does not alter the spread of feline immunodeficiency virus infection in cats.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Jun-01, Volume: 9, Issue:2

    Topics: Animals; Antibodies, Viral; Antigens, Viral; Cats; CD4-CD8 Ratio; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Feline Acquired Immunodeficiency Syndrome; Immunodeficiency Virus, Feline; Immunophenotyping; Polymerase Chain Reaction; Viremia; Zidovudine

1995
The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Jul-01, Volume: 9, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Prognosis; Prospective Studies; Viremia; Virus Replication; Zidovudine

1995
Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes.
    Journal of clinical microbiology, 1994, Volume: 32, Issue:9

    Topics: Anticoagulants; Blood Specimen Collection; CD4 Lymphocyte Count; Culture Media; Didanosine; DNA, Viral; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Evaluation Studies as Topic; False Negative Reactions; Gels; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Polyesters; Polymerase Chain Reaction; Predictive Value of Tests; RNA, Viral; Severity of Illness Index; Specimen Handling; Viremia; Virus Cultivation; Zidovudine

1994
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Apr-01, Volume: 8, Issue:4

    Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Didanosine; DNA, Viral; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Polymerase Chain Reaction; Proviruses; RNA, Viral; Viremia; Virion; Zidovudine

1995
Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
    AIDS (London, England), 1993, Volume: 7 Suppl 2

    Topics: Biomarkers; CD4-Positive T-Lymphocytes; Evaluation Studies as Topic; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Time Factors; Viremia; Zidovudine

1993
Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
    AIDS (London, England), 1994, Volume: 8, Issue:1

    Topics: Adult; Biomarkers; CD4-Positive T-Lymphocytes; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Prospective Studies; Viremia; Zidovudine

1994
Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
    Journal of acquired immune deficiency syndromes, 1994, Volume: 7, Issue:10

    Topics: Adult; beta 2-Microglobulin; Biopterins; CD4-Positive T-Lymphocytes; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Immunoglobulin A; Leukocyte Count; Male; Middle Aged; Neopterin; Prognosis; Proportional Hazards Models; T-Lymphocytes, Regulatory; Thymidine Kinase; Viremia; Zidovudine

1994
Relationship between anti-p24 antibody levels and p24 antigenemia in HIV-infected patients.
    AIDS research and human retroviruses, 1993, Volume: 9, Issue:12

    Topics: Antigen-Antibody Complex; Didanosine; HIV Antibodies; HIV Core Protein p24; HIV Infections; Humans; Prognosis; Viremia; Zidovudine

1993
Prophylactic ZDV dosing frequency in macaques.
    Journal of acquired immune deficiency syndromes, 1994, Volume: 7, Issue:6

    Topics: Animals; Macaca mulatta; Simian Acquired Immunodeficiency Syndrome; Viremia; Zidovudine

1994
Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats.
    Journal of acquired immune deficiency syndromes, 1993, Volume: 6, Issue:2

    Topics: Age Factors; Aging; Animals; Antibodies, Viral; Antigens, Viral; Blotting, Southern; Cats; CD4-CD8 Ratio; Disease Models, Animal; Electrophoresis, Agar Gel; Feline Acquired Immunodeficiency Syndrome; Immunodeficiency Virus, Feline; Immunophenotyping; Infusions, Parenteral; Leukocyte Count; Lymphocytes; Polymerase Chain Reaction; Specific Pathogen-Free Organisms; Viremia; Zidovudine

1993
Reversal of feline leukemia virus infection by adoptive transfer of lectin/interleukin-2-activated lymphocytes, interferon-alpha, and zidovudine.
    Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 1993, Volume: 14, Issue:1

    Topics: Animals; Antibody Formation; Cats; Combined Modality Therapy; Concanavalin A; Cytotoxicity, Immunologic; Feline Acquired Immunodeficiency Syndrome; Humans; Immunotherapy, Adoptive; In Vitro Techniques; Interferon alpha-2; Interferon-alpha; Interleukin-2; Leukemia Virus, Feline; Lymphocyte Activation; Lymphocytes; Neutralization Tests; Phenotype; Recombinant Proteins; Viremia; Zidovudine

1993
Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus.
    Journal of acquired immune deficiency syndromes, 1993, Volume: 6, Issue:10

    Topics: Anemia; Animals; Antibodies, Viral; Base Sequence; DNA Primers; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Leukocytes, Mononuclear; Lymph Nodes; Lymphocyte Subsets; Macaca fascicularis; Male; Molecular Sequence Data; Polymerase Chain Reaction; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Viremia; Zidovudine

1993
Comparative study of the isolation of human immunodeficiency virus from the lung and peripheral blood of AIDS patients.
    Journal of medical virology, 1993, Volume: 39, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Bronchoalveolar Lavage Fluid; DNA, Viral; HIV Seropositivity; HIV-1; Humans; Lung; Polymerase Chain Reaction; Viremia; Zidovudine

1993
p24 antigenaemia and clinical response to zidovudine therapy.
    AIDS (London, England), 1993, Volume: 7, Issue:3

    Topics: Adult; Blood; Cohort Studies; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Viremia; Virus Replication; Zidovudine

1993
Plasma viral load, CD4+ cell counts, and HIV-1 production by cells.
    Science (New York, N.Y.), 1996, Feb-02, Volume: 271, Issue:5249

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Cells, Cultured; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Lymphocyte Count; T-Lymphocytes; Tumor Cells, Cultured; Viremia; Virus Replication; Zidovudine

1996
Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1996, Apr-15, Volume: 11, Issue:5

    Topics: Adult; Antiviral Agents; Consensus Sequence; DNA, Viral; Female; Giant Cells; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Kinetics; Leukocytes, Mononuclear; Male; Middle Aged; Neutralization Tests; Peptide Fragments; Proviruses; RNA, Viral; Viremia; Zidovudine

1996
Tumor necrosis factor-alpha in serum of macaques during SIVmac251 acute infection.
    Journal of medical primatology, 1995, Volume: 24, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Biomarkers; Disease Models, Animal; Female; HIV; Humans; Macaca fascicularis; Male; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Tumor Necrosis Factor-alpha; Viremia; Virus Replication; Zidovudine

1995
Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.
    American journal of obstetrics and gynecology, 1996, Volume: 175, Issue:1

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Cervix Uteri; Female; HIV Infections; HIV-1; Humans; RNA, Viral; Vagina; Viremia; Zidovudine

1996
Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma.
    The Journal of infectious diseases, 1996, Volume: 174, Issue:2

    Topics: Antiviral Agents; Biopsy; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Kinetics; Lamivudine; Lymph Nodes; RNA, Viral; Viremia; Zalcitabine; Zidovudine

1996
Quantification of low levels of human immunodeficiency virus (HIV) type 1 RNA in P24 antigen-negative, asymptomatic, HIV-positive patients by PCR.
    Journal of clinical microbiology, 1996, Volume: 34, Issue:2

    Topics: Antiviral Agents; Evaluation Studies as Topic; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Interferon-alpha; Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Viremia; Zidovudine

1996
Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virus.
    The Journal of pediatrics, 1996, Volume: 129, Issue:3

    Topics: Antiviral Agents; Biopsy; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; In Situ Hybridization; Infant; Lymph Nodes; Male; Nevirapine; Pyridines; Viremia; Zidovudine

1996
Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients.
    AIDS research and human retroviruses, 1996, Jan-01, Volume: 12, Issue:1

    Topics: Biomarkers; CD4 Lymphocyte Count; Child; Child, Preschool; DNA, Viral; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Male; RNA, Viral; Treatment Outcome; Viremia; Virus Integration; Zidovudine

1996
An update on HIV/AIDS.
    Journal of the American Dental Association (1939), 1996, Volume: 127, Issue:9

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; United States; Viremia; Zidovudine

1996
Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacy.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:9

    Topics: Animals; Anti-HIV Agents; Cats; Infusions, Intravenous; Leukemia Virus, Feline; Retroviridae Infections; Time Factors; Tumor Virus Infections; Viremia; Zidovudine

1996
Combined therapy with zidovudine and L-697,661 in primary HIV infection.
    AIDS (London, England), 1996, Volume: 10, Issue:11

    Topics: Adult; Anti-HIV Agents; Benzoxazoles; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; DNA, Viral; Drug Therapy, Combination; HIV Infections; Humans; Pyridones; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Viremia; Zidovudine

1996
HIV-1 viraemia changes in patients with and without syncytium-inducing phenotype treated with nucleoside analogues: a case-control study.
    European journal of clinical investigation, 1996, Volume: 26, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Female; HIV-1; Humans; Male; Middle Aged; Phenotype; RNA, Viral; Viremia; Zidovudine

1996
Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus.
    The Journal of pediatrics, 1997, Volume: 130, Issue:2

    Topics: Adolescent; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Male; RNA, Viral; Time Factors; Viral Load; Viremia; Zidovudine

1997
Decay characteristics of HIV-1-infected compartments during combination therapy.
    Nature, 1997, May-08, Volume: 387, Issue:6629

    Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; Half-Life; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Lamivudine; Leukocytes, Mononuclear; Macrophages; Mathematics; Models, Biological; Nelfinavir; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Sulfonic Acids; Viral Load; Viremia; Virus Latency; Zidovudine

1997
Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Apr-15, Volume: 14, Issue:5

    Topics: Anti-HIV Agents; beta 2-Microglobulin; CD4 Lymphocyte Count; Didanosine; Disease Progression; DNA, Viral; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Longitudinal Studies; RNA, Viral; Stavudine; Viral Load; Viremia; Virus Replication; Zalcitabine; Zidovudine

1997
Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy.
    AIDS (London, England), 1997, Volume: 11, Issue:7

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Lymph Nodes; Male; Polymerase Chain Reaction; RNA, Viral; Saquinavir; Viral Load; Viremia; Zidovudine

1997
Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment.
    AIDS (London, England), 1997, Volume: 11, Issue:11

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Indinavir; Models, Biological; Nevirapine; Pyridines; Risk Factors; RNA, Viral; Substance Withdrawal Syndrome; Viral Load; Viremia; Zidovudine

1997
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
    Science (New York, N.Y.), 1997, Nov-14, Volume: 278, Issue:5341

    Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Coculture Techniques; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Lymphocyte Activation; Mutation; RNA, Viral; T-Lymphocyte Subsets; Viral Load; Viremia; Virus Activation; Virus Latency; Virus Replication; Zidovudine

1997
thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues.
    The Journal of infectious diseases, 1998, Volume: 177, Issue:2

    Topics: Animals; Anti-HIV Agents; Chronic Disease; Drug Resistance, Microbial; Drug Therapy, Combination; Fetal Tissue Transplantation; Flow Cytometry; HIV Infections; HIV-1; Lamivudine; Leukocytes, Mononuclear; Liver Transplantation; Mice; Mice, SCID; Recurrence; Ritonavir; RNA, Viral; Saquinavir; Thymus Gland; Viremia; Zidovudine

1998
Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients.
    Viral immunology, 1997, Volume: 10, Issue:4

    Topics: Adult; Anti-HIV Agents; CD8-Positive T-Lymphocytes; Cell Count; Didanosine; Drug Therapy, Combination; Flow Cytometry; HIV Seropositivity; HIV-1; Humans; Male; Phenotype; RNA, Viral; Viremia; Zidovudine

1997
Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine.
    AIDS (London, England), 1998, Mar-05, Volume: 12, Issue:4

    Topics: Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Codon; Drug Resistance, Microbial; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Mutation; Polymerase Chain Reaction; Retrospective Studies; RNA, Viral; Viral Load; Viremia; Zidovudine

1998
Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Apr-01, Volume: 17, Issue:4

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; DNA, Circular; DNA, Viral; Follow-Up Studies; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Phenotype; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; RNA, Viral; Viremia; Zidovudine

1998
Sustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia and p24 antigenemia.
    Journal of neurovirology, 1998, Volume: 4, Issue:1

    Topics: Adult; AIDS Dementia Complex; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; HIV Core Protein p24; HIV-1; Humans; Longitudinal Studies; Male; Middle Aged; Viremia; Zidovudine

1998
Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
    AIDS (London, England), 1998, May-07, Volume: 12, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Female; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sarcoma, Kaposi; Stavudine; Treatment Outcome; Viral Load; Viremia; Zalcitabine; Zidovudine

1998
[HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allergie et immunologie, 1998, Volume: 30, Issue:4

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Evaluation; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viremia; Zidovudine

1998
Transient dissociation between infectious HIV-1 titer and viral RNA during the early phase of AZT treatment.
    Microbiology and immunology, 1998, Volume: 42, Issue:6

    Topics: Adult; Anti-HIV Agents; Enzyme-Linked Immunosorbent Assay; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Prospective Studies; RNA, Viral; Time Factors; Viremia; Zidovudine

1998
Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.
    Journal of virology, 1999, Volume: 73, Issue:8

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cytotoxicity, Immunologic; Drug Therapy, Combination; Epitopes, T-Lymphocyte; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Longitudinal Studies; Reverse Transcriptase Inhibitors; Stavudine; T-Lymphocytes, Cytotoxic; Viral Load; Viremia; Zidovudine

1999
Antiviral effect of AZT versus stavudine in combination with lamivudine and indinavir in the context of a populational study.
    Journal of acquired immune deficiency syndromes (1999), 1999, Aug-01, Volume: 21, Issue:4

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Stavudine; Viremia; Zidovudine

1999
Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17

    Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Adult; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; HIV Infections; HIV-1; HLA-DR Antigens; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Male; Membrane Glycoproteins; NAD+ Nucleosidase; Palatine Tonsil; Proviruses; T-Lymphocyte Subsets; Time Factors; Viremia; Virus Replication; Zidovudine

1999
Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals.
    Scandinavian journal of immunology, 2000, Volume: 51, Issue:2

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; HIV Infections; HIV-1; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Leukocytes, Mononuclear; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Viremia; Zidovudine

2000
Kinetics of productive and latent HIV infection in lymphatic tissue and peripheral blood during triple-drug combination therapy with or without additional interleukin-2.
    Antiviral therapy, 1998, Volume: 3, Issue:4

    Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Interleukin-2; Kinetics; Lymphoid Tissue; Male; Middle Aged; RNA, Viral; Saquinavir; Viremia; Zalcitabine; Zidovudine

1998
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.
    Blood, 2000, Mar-01, Volume: 95, Issue:5

    Topics: Acute Disease; Anti-HIV Agents; Clone Cells; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Saquinavir; T-Lymphocytes, Cytotoxic; Viremia; Zidovudine

2000
Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    AIDS research and human retroviruses, 2000, Feb-10, Volume: 16, Issue:3

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Male; Palatine Tonsil; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Time Factors; Viremia; Zidovudine

2000
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.
    The Journal of clinical investigation, 2000, Volume: 105, Issue:6

    Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Dideoxynucleosides; Furans; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Lymph Nodes; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Stavudine; Sulfonamides; Time Factors; Viral Load; Viremia; Zidovudine

2000
Onset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-1-infected child.
    AIDS (London, England), 2000, Jun-16, Volume: 14, Issue:9

    Topics: Anti-HIV Agents; Antibody Formation; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Antibodies; HIV Infections; HIV Seronegativity; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Viremia; Zidovudine

2000
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Jan-16, Volume: 98, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Depression, Chemical; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxyurea; Immunity, Cellular; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Refusal; Viral Load; Viremia; Zidovudine

2001
Detection of resistant mutations in the reverse transcriptase of HIV-1-infected children.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6, Issue:5

    Topics: CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Male; Mutation; Reverse Transcriptase Inhibitors; Ritonavir; Viremia; Zidovudine

2000
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2000, Volume: 4, Issue:4

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Polymerase Chain Reaction; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viremia; Zidovudine

2000
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.
    The Journal of infectious diseases, 2001, May-01, Volume: 183, Issue:9

    Topics: Cohort Studies; DNA, Viral; Female; Genitalia; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Lymph Nodes; Male; Molecular Sequence Data; Randomized Controlled Trials as Topic; RNA, Viral; Time Factors; Viral Load; Viremia; Virus Replication; Zidovudine

2001
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:2

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Statistics, Nonparametric; Viral Load; Viremia; Virus Shedding; Zidovudine

2001
Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patients.
    Antiviral therapy, 1996, Volume: 1, Issue:3

    Topics: Anti-HIV Agents; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Lamivudine; RNA, Viral; Viremia; Zidovudine

1996
Viraemia and p24 antigenaemia are independent risk factors for the emergency of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection.
    Antiviral therapy, 1997, Volume: 2, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Resistance, Microbial; Female; Genotype; HIV Core Protein p24; HIV-1; Humans; Male; Retrospective Studies; Risk Factors; RNA, Viral; Viremia; Zidovudine

1997
Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission.
    Pediatric AIDS and HIV infection, 1995, Volume: 6, Issue:6

    Topics: CD4 Lymphocyte Count; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; RNA, Viral; Time Factors; Viremia; Zidovudine

1995
Antiretroviral drug resistance.
    AIDS clinical care, 1995, Volume: 7, Issue:8

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; RNA, Viral; Stavudine; Viremia; Zalcitabine; Zidovudine

1995
Conference looks at HIV drug resistance.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:9

    Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine

1995
Mothers shown to transmit resistant strains to babies.
    AIDS alert, 1995, Volume: 10, Issue:11

    Topics: Antiviral Agents; HIV; HIV Infections; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Viremia; Zidovudine

1995
Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization.
    AIDS research and human retroviruses, 2001, May-01, Volume: 17, Issue:7

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Progression; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Lymphoid Tissue; Phenotype; Proviruses; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine

2001
Prevalence and predictive value of intermittent viremia with combination hiv therapy.
    JAMA, 2001, Jul-11, Volume: 286, Issue:2

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Predictive Value of Tests; Prevalence; Proportional Hazards Models; Retrospective Studies; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine

2001
Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.
    AIDS research and human retroviruses, 2001, Aug-10, Volume: 17, Issue:12

    Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Viremia; Zidovudine

2001
Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    AIDS (London, England), 2002, Mar-08, Volume: 16, Issue:4

    Topics: Adult; Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; Biomarkers; Carbamates; CD48 Antigen; CD8-Positive T-Lymphocytes; Dideoxynucleosides; Female; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lymphocyte Count; Male; Middle Aged; Reverse Transcriptase Inhibitors; Sulfonamides; T-Lymphocyte Subsets; Treatment Outcome; Viral Load; Viremia; Zidovudine

2002
Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis.
    AIDS (London, England), 2002, May-03, Volume: 16, Issue:7

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Dideoxynucleosides; Drug Evaluation; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; London; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Viremia; Zidovudine

2002
Needlestick transmission of hepatitis C.
    JAMA, 2002, May-08, Volume: 287, Issue:18

    Topics: Accidents, Occupational; Acute Disease; Adult; Anti-HIV Agents; Antiviral Agents; Asthenia; Exanthema; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Interferon alpha-2; Interferon-alpha; Internship and Residency; Lamivudine; Needlestick Injuries; Nelfinavir; Occupational Exposure; Physicians; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viremia; Zidovudine

2002
Short-term evaluation of zidovudine-treated patients: decrease in plasma and cellular viraemia titres.
    AIDS (London, England), 1992, Volume: 6, Issue:11

    Topics: CD4-Positive T-Lymphocytes; Evaluation Studies as Topic; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Time Factors; Viremia; Zidovudine

1992
Quantitation of human immunodeficiency virus (HIV) with respect to disease stage and zidovudine (AZT) therapy.
    AIDS research and human retroviruses, 1992, Volume: 8, Issue:7

    Topics: Cells, Cultured; Female; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Leukocytes, Mononuclear; Male; Viremia; Zidovudine

1992
HIV-1 isolation from small amounts of whole blood: a technical evaluation.
    Microbiologica, 1992, Volume: 15, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Cell Line; Cells, Cultured; Cryopreservation; Edetic Acid; Evaluation Studies as Topic; Heparin; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Kinetics; Leukocytes, Mononuclear; Sensitivity and Specificity; Time Factors; Viremia; Virus Replication; Zidovudine

1992
Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.
    The Journal of infectious diseases, 1991, Volume: 163, Issue:4

    Topics: Adult; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Female; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Interferon Type I; Leukocyte Count; Male; Middle Aged; Viral Core Proteins; Viremia; Zidovudine

1991
High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.
    The Journal of infectious diseases, 1991, Volume: 164, Issue:1

    Topics: Adult; CD4-Positive T-Lymphocytes; Child; Gene Products, gag; HIV Antibodies; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Reproducibility of Results; Viral Core Proteins; Viremia; Zidovudine

1991
Population dynamics of HIV within an individual after treatment with zidovudine.
    AIDS (London, England), 1991, Volume: 5, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Leukocyte Count; Models, Theoretical; Time Factors; Viremia; Zidovudine

1991
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment.
    Journal of acquired immune deficiency syndromes, 1992, Volume: 5, Issue:2

    Topics: AIDS-Related Complex; Chi-Square Distribution; HIV; HIV Core Protein p24; HIV Infections; Humans; Regression Analysis; Sensitivity and Specificity; Viremia; Virus Cultivation; Zidovudine

1992
Transplacental antiretroviral therapy with 9-(2-phosphonylmethoxyethyl)adenine is embryotoxic in transgenic mice.
    Journal of acquired immune deficiency syndromes, 1991, Volume: 4, Issue:9

    Topics: Adenine; Animals; Antiviral Agents; Embryo, Mammalian; Female; Fetal Resorption; Litter Size; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Mice, Transgenic; Moloney murine leukemia virus; Organophosphonates; Pregnancy; Viremia; Zidovudine

1991
Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy.
    Journal of medical virology, 1991, Volume: 35, Issue:1

    Topics: Base Sequence; DNA, Viral; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Longitudinal Studies; Molecular Sequence Data; Polymerase Chain Reaction; Prognosis; RNA, Viral; Viremia; Zidovudine

1991
Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice.
    Journal of acquired immune deficiency syndromes, 1991, Volume: 4, Issue:5

    Topics: Animals; Antibodies, Viral; Cells, Cultured; Female; Friend murine leukemia virus; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Neutralization Tests; Recurrence; Splenomegaly; T-Lymphocytes; Viremia; Virus Cultivation; Virus Replication; Zidovudine

1991
[Virological monitoring in subjects with HIV infection under treatment with zidovudine (AZT)].
    Bollettino della Societa italiana di biologia sperimentale, 1990, Volume: 66, Issue:6

    Topics: Gene Products, gag; HIV; HIV Core Protein p24; HIV Infections; Humans; Viral Core Proteins; Viremia; Virus Replication; Zidovudine

1990
Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure.
    Journal of acquired immune deficiency syndromes, 1990, Volume: 3, Issue:6

    Topics: Animals; Cell Line; Drug Synergism; Drug Therapy, Combination; Female; Interferon Type I; Mice; Mice, Inbred BALB C; Rauscher Virus; Recombinant Proteins; Retroviridae Infections; Viremia; Virus Replication; Zidovudine

1990
Cytomegalovirus viremia in HIV-infected patients treated with zidovudine.
    Scandinavian journal of infectious diseases, 1990, Volume: 22, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Cytomegalovirus; Cytomegalovirus Infections; Female; HIV-1; Humans; Male; Middle Aged; Time Factors; Viremia; Zidovudine

1990
Murine models for antiretroviral therapy.
    Intervirology, 1989, Volume: 30 Suppl 1

    Topics: Acquired Immunodeficiency Syndrome; Animals; Combined Modality Therapy; Disease Models, Animal; Drug Evaluation, Preclinical; Interferon Type I; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Rauscher Virus; Recombinant Proteins; Retroviridae; Retroviridae Infections; Viremia; Zidovudine

1989
Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
    The New England journal of medicine, 1989, Dec-14, Volume: 321, Issue:24

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Blood; Cytopathogenic Effect, Viral; Female; HIV-1; Humans; Leukocytes, Mononuclear; Male; Viremia; Zidovudine

1989
Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy.
    The New England journal of medicine, 1989, Dec-14, Volume: 321, Issue:24

    Topics: Acquired Immunodeficiency Syndrome; Blood; HIV-1; Humans; Viremia; Zidovudine

1989